Gao Leilei, Dong Bin, Zhang Junmei, Chen Ying, Qiao Haishi, Liu Zhihong, Chen Enping, Dong Yuqin, Cao Chongjiang, Huang Dechun, Chen Wei
ACS Macro Lett. 2019 Dec 17;8(12):1552-1558. doi: 10.1021/acsmacrolett.9b00758. Epub 2019 Nov 14.
Nitric oxide (NO), as a bioeffector to improve chemosensitivity by reversing multidrug resistance (MDR), is highly attractive for developing combinational delivery systems to deal with MDR tumors, while it is highly challenged by the stability and controlled release of NO during the pathway. Here we design and synthesize a cyclic nitrate trimethylene carbonate monomer (NTC), followed by ring-opening polymerization to prepare amphiphilic biodegradable polycarbonate-based copolymers as polymeric NO donors with tailored contents. The copolymer with desirable molecular weight is readily self-assembled to biodegradable micelles (NO-M) with a uniform size of 130 nm for highly stabilizing NO donors at the physiological conditions, while triggered NO release from micelles is performed at the intracellular reduction conditions. More importantly, NO-M shows superior inhibition of P-gP expression to enhance the chemosensitivity of multidrug-resistant MCF7 cells (MCF7/DOX). DOX-loaded NO-M (NO-M@DOX) realizes fast DOX release at the intracellular conditions, resulting in more intracellular DOX accumulation and higher antitumor activity mediated by the reduction-triggered NO/DOX release and NO-induced MDR reversal. Furthermore, the in vivo results show that NO-M@DOX effectively suppresses the MCF7/DOX tumor growth by a combination of directly NO-induced therapy and NO-mediated enhanced chemotherapy; meanwhile, the treatment with NO-M systems have much fewer side effects.
一氧化氮(NO)作为一种通过逆转多药耐药性(MDR)来提高化学敏感性的生物效应剂,对于开发用于治疗MDR肿瘤的组合递送系统极具吸引力,然而在该过程中,NO的稳定性和控释面临着巨大挑战。在此,我们设计并合成了一种环状硝酸酯三亚甲基碳酸酯单体(NTC),随后通过开环聚合制备两亲性可生物降解的聚碳酸酯基共聚物,作为具有定制含量的聚合物NO供体。具有理想分子量的共聚物易于自组装成尺寸均匀为130 nm的可生物降解胶束(NO-M),以便在生理条件下高度稳定NO供体,而胶束在细胞内还原条件下会触发NO释放。更重要的是,NO-M对P-gP表达具有优异的抑制作用,从而增强多药耐药MCF7细胞(MCF7/DOX)的化学敏感性。负载阿霉素的NO-M(NO-M@DOX)在细胞内条件下实现阿霉素的快速释放,导致更多的阿霉素在细胞内积累,并通过还原触发的NO/阿霉素释放和NO诱导的MDR逆转介导更高的抗肿瘤活性。此外,体内结果表明,NO-M@DOX通过直接的NO诱导治疗和NO介导的增强化疗相结合,有效抑制了MCF7/DOX肿瘤的生长;同时,使用NO-M系统进行治疗的副作用要少得多。